Released Jul 20, 2021, after the close
10-Q filed Jul 21, 2021, 21 days after period end · 0001035267-21-000119
Q2 2021 · 10-Q
Revenue$1.46B$1.46B +71.8% vs Q2 2020+13.3% vs Q1 2021
Net Income$517.20M$517.20M +660.6% vs Q2 2020+21.3% vs Q1 2021
EPS Diluted$1.42$1.42 +149.1% vs Q2 2020+21.4% vs Q1 2021
Gross Profit$1,023,700,000+103.6%
Operating Income$511,200,000+534.2%
Operating Cash Flowderived$542,700,000+136.1%
Free Cash Flowderived$467,000,000+289.5%
Margins · derived
Gross margin69.9%+10.9 pt vs Q2 2020
Operating margin34.9%+25.5 pt vs Q2 2020
Net margin35.3%+27.3 pt vs Q2 2020
What the release said
The release
Same quarter
| Metric | Q2 2021 | Q2 2020 | Q2 2019 | Q2 2018 |
|---|---|---|---|---|
| Revenue | $1.46B | $852.10M | $1.10B | $909.30M |
| Net Income | $517.20M | $68.00M | $318.30M | $255.30M |
| EPS Diluted | $1.42 | $0.57 | $2.67 | $2.15 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Intuitive Surgical Inc · CIK 1035267 · Engraved from SEC EDGAR